Bom-Benge ointment, 25 g

• Rheumatism (articular and muscular);

• arthritis;

• exudative pleurisy;

• lumboishalgia;

• radiculitis;

• myalgia;

• muscle pain (before and after sports).

Outwardly. The required amount of ointment (2-4 g for adults and 1-3 g for children aged 12 to 18 years) is applied to the painful area and rubbed. If necessary, the procedure is repeated after a few hours (up to 3 times a day). The duration of the course (without consulting a doctor) is up to 10 days. If after 10 days of treatment there is no improvement or symptoms worsen, or new symptoms appear, you should consult your doctor. Use the drug only according to the indications, the route of administration and the doses indicated in the instructions.

Active ingredients:

L-menthol - 3.9 g; methyl salicylate - 20.2 g

Excipients: petroleum paraffins, solid grades P-1, P-2 - 7 g; medical petroleum jelly - up to 100 g.

• Hypersensitivity;

• violation of the integrity of the skin;

• inflammatory skin diseases at the site of the intended application;

• III trimester of pregnancy;

• breastfeeding period;

• children under 18 years of age.

  Carefully

• Intolerance to salicylic acid derivatives; I-II trimesters of pregnancy.

pharmachologic effect

Combined drug, has a local anti-inflammatory and analgesic effect.

Side effect

Local reactions: allergic reactions (itching, urticaria, skin rash).

Application during pregnancy and lactation

Contraindicated in the third trimester of pregnancy and during lactation (breastfeeding). It is used in the I-II trimesters of pregnancy only if the intended benefit to the mother outweighs the potential risk to the fetus.

Application in children

The use is contraindicated in children under 18 years of age.

special instructions

Avoid contact with the conjunctiva and other mucous membranes.

Do not apply to damaged or irritated skin.

Do not use with warming compresses.

Do not use with oral anticoagulants.

Drug interactions

The drug causes flushing of the skin and reflexively enhances blood circulation in the subcutaneous tissue - combined use with other drugs of local action can lead to an increase in their absorption.

This drug in large quantities may increase the toxicity of methotrexate.

This drug in large quantities can reduce the therapeutic effect of hypoglycemic agents.